Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy

Affiliations

• ¹ School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, China.
• ² Phase I Clinical Trials Unit, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
• ³ Nanjing Drum Tower Hospital, Clinical College of Nanjing, University of Chinese Medicine, Nanjing, China.
• ⁴ Department of Pharmacology and Toxicology, Rutgers, The State University of New Jersey, Piscataway, NJ, United States.
• ⁵ State Key Laboratory of Natural Medicines, Department of Physiology, China Pharmaceutical University, Nanjing, Jiangsu, China.
• ⁶ General Clinical Research Center, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.